🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase 1-2 trial studies the side effects and how well tipifarnib works...
Status
Completed
Location
Stanford Cancer Institute
Start Date
2000-05
Trial ID
NCT02210858
Treatments Being Tested
This phase II Pediatric MATCH screening and multi-sub-trial studies how wel...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-07-31
Trial ID
NCT03155620
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
NYU Cancer Institute at New York University Medical Center
Start Date
2000-08
Trial ID
NCT00005990
Treatments Being Tested
The purpose of this study is to evaluate the investigational drug, tipifarn...
Status
Recruiting
Location
Arkansas Children's Hospital
Start Date
2024-12-06
Trial ID
NCT06540963
Treatments Being Tested
Drugs used in chemotherapy, such as doxorubicin and cyclophosphamide, work ...
Status
Completed
Location
Albert Einstein College of Medicine
Start Date
2003-02
Trial ID
NCT00049114
This study will examine whether the experimental drug R115777 (Tipifarnib) ...
Status
Completed
Location
University of Alabama at Birmingham (M1149)
Start Date
2001-07-17
Trial ID
NCT00021541
Treatments Being Tested
The goal of this clinical research study is to find the highest safe dose o...
Status
Completed
Location
MD Anderson Cancer Center
Start Date
2002-12
Trial ID
NCT00050986
Treatments Being Tested
This phase II pediatric MATCH trial studies how well tipifarnib works in tr...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2020-10-13
Trial ID
NCT04284774
Treatments Being Tested
RATIONALE: Tipifarnib may stop the growth of tumor cells by blocking the en...
Status
Completed
Location
University of Chicago Cancer Research Center
Start Date
2002-11
Trial ID
NCT00047216
Treatments Being Tested
RATIONALE: Tipifarnib may stop the growth of tumor cells by blocking the en...
Status
Withdrawn
Location
Multiple Locations
Start Date
2002-12
Trial ID
NCT00054470
Treatments Being Tested